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Overexpression of the scaffoldWD40 proteinWRAP53β
enhances the repair of and cell survival from DNA
double-strand breaks
H Rassoolzadeh1,3, S Böhm1,3, E Hedström1, H Gad2, T Helleday2, S Henriksson1 and M Farnebo*,1
Altered expression of the multifunctional protein WRAP53β (WD40 encoding RNA Antisense to p53), which targets repair factors to
DNA double-strand breaks and factors involved in telomere elongation to Cajal bodies, is linked to carcinogenesis. While loss of
WRAP53β function has been shown to disrupt processes regulated by this protein, the consequences of its overexpression remain
unclear. Here we demonstrate that overexpression of WRAP53β disrupts the formation of and impairs the localization of coilin to
Cajal bodies. At the same time, the function of this protein in the repair of DNA double-strand breaks is enhanced. Following
irradiation, cells overexpressing WRAP53β exhibit more rapid clearance of phospho-histone H2AX (γH2AX), and more efficient
homologous recombination and non-homologous end-joining, in association with fewer DNA breaks. Moreover, in these cells the
ubiquitylation of damaged chromatin, which is known to facilitate the recruitment of repair factors and subsequent repair, is
elevated. Knockdown of the ubiquitin ligase involved, ring-finger protein 8 (RNF8), which is recruited to DNA breaks by WRAP53β,
attenuated this effect, suggesting that overexpression of WRAP53β leads to more rapid repair, as well as improved cell survival, by
enhancing RNF8-mediated ubiquitylation at DNA breaks. Our present findings indicate that WRAP53β and RNF8 are rate-limiting
factors in the repair of DNA double-strand breaks and raise the possibility that upregulation of WRAP53β may contribute to
genomic stability in and survival of cancer cells.
Cell Death and Disease (2016) 7, e2267; doi:10.1038/cddis.2016.172; published online 16 June 2016
We previously identified the RNA produced from theWRAP53
(WD40 encoding RNAAntisense to p53) gene as an antisense
transcript (WRAP53α) that stabilizes the tumor suppressor
p53.1 In addition, this gene encodes the WRAP53β protein
(also referred to as WRAP53 or WDR79 or TCAB1), which
does not regulate p53 but instead is involved in the regulation
of telomere elongation and repair of DNA double-strand
breaks by recruiting telomerase to nuclear Cajal bodies and
the repair factor RNF8 to these break, respectively.2,3 The role
played by WRAP53β in the repair of DNA double-strand
breaks is independent of p53, as WRAP53β regulates DNA
repair also in cells that lack p53 expression.3,4WRAP53β also
directs coilin, the survival of motor neuron (SMN) protein and
small Cajal body-associated (sca) RNAs to Cajal bodies.2,5,6
Several lines of evidence indicate that WRAP53β itself also
acts as a tumor suppressor. For example, mutations that
attenuate its nuclear localization and telomere function cause
dyskeratosis congenita, which enhances the risk for develop-
ing cancer.7,8 These mutations also prevent binding to the
DNA repair factor γH2AX required for the accumulation of
WRAP53β at DNA breaks,9 indicating that disturbed DNA
repair may contribute to the pathogenesis of dyskeratosis
congenita. Furthermore, loss of nuclear WRAP53β or single-
nucleotide polymorphisms in the WRAP53 gene is correlated
with shorter survival of patients with head and neck, breast
and ovarian cancer.4,10–15 In addition, attenuated expression
of this protein correlates with disruption of the DNA damage
response in ovarian tumors,4 aswell aswith resistance of head
and neck cancer to radiotherapy.14 Accordingly, altered DNA
repair may be the underlying cause of cancers associated with
abnormalities in WRAP53β and influence the response of
such tumors to treatment.
At the same time, overexpression of WRAP53β is observed
in a variety of cancer cell lines compared with non-transformed
cells.16WRAP53β is also overexpressed in primary nasophar-
yngeal carcinoma,17 esophageal squamous cell carcinoma,18
non-small-cell lung cancer19 and rectal cancer20 and knock-
down of this protein in cancer cells subsequently grafted into
mice reduces the size of the tumors formed.17,19 In esopha-
geal squamous cell carcinoma, overexpression of WRAP53β
was significantly correlated with tumor infiltration depth,
clinical stage and lymph node metastasis.18 However, for
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none of the studies mentioned above significant associations
between WRAP53β overexpression and patient survival were
demonstrated. Therefore, although WRAP53β is clearly over-
expressed in some tumor types, the clinical relevance of such
overexpression remains unclear.
Thus, while loss of WRAP53β function impairs DNA repair
and telomere maintenance, which enhances genomic instabil-
ity and carcinogenesis, the role of WRAP53β overexpression
in connection with carcinogenesis is poorly understood. Here,
we examined the potential influence of such overexpression
on the DNA damage response.
Results
Overexpression of WRAP53β disrupts Cajal bodies and
the overexpressed protein is mainly soluble. The
WRAP53β protein is highly enriched in Cajal bodies, and to
examine whether this localization is altered upon overexpres-
sion, the total protein lysate from human U-2 osteosarcoma
(U2OS) cancer cells that stably overexpress Flag-tagged
WRAP53β was analyzed with both rabbit α-WRAP53-C2
antibody, which detects both the nuclear and cytoplasmic
forms, and the mouse monoclonal α-WDR79 clone 1F12,
which detects the nuclear variant, and is the only antibody that
can be used to visualize this protein in repair foci.3,4
Examination of western blots with either of these antibodies
revealed elevated expression of WRAP53β (Figure 1a).
Immunostaining of WRAP53β and its interaction partner
coilin (a marker for Cajal bodies) in control cells expressing
endogenous WRAP53β revealed enrichment of both of these
factors in Cajal bodies, as expected (Figure 1b).5 In contrast,
no Cajal bodies were observed in the cells overexpressing
WRAP53β, where this protein and coilin were distributed
throughout the nucleoplasm (Figure 1b), in agreement with
previous findings.5 Nor did reduction of background nucleo-
plasmic staining through pre-extraction of soluble proteins
uncover any accumulation of WRAP53β or coilin in Cajal
bodies in the cells overexpressing WRAP53β, although this
treatment reduced totalWRAP53β staining, potently indicating
that most of the overexpressed protein is soluble (Figure 1c).
Indeed, western blotting of the soluble and chromatin proteins
of WRAP53β-overexpressing cells confirmed that most of the
overexpressed WRAP53β was soluble, although the amount
of this protein bound to chromatin also is increased
(Figure 1d). Taken together, these findings demonstrate that
overexpression of WRAP53β impairs accumulation of both
this protein itself and coilin in Cajal bodies, with most of the
overexpressed WRAP53β being in soluble form.
Overexpression of WRAP53β does not influence its
recruitment to sites of DNA damage. Next, we explored
the localization of WRAP53β following exposure of cells to
ionizing radiation (IR), which causes DNA double-strand
breaks. WRAP53β localized rapidly to these breaks, to an
extent of 84% in overexpressing cells in comparison with only
77% in the control cells (Figure 2a), which may simply reflect
better visualization because of higher amounts of WRAP53β
in the repair foci of the former. These foci also contained
γH2AX, a marker for sites of DNA damage known to interact
with WRAP53β (Figure 2a).9
Ubiquitylation of damaged chromatin, a process regulated
by the ubiquitin ligases RNF8 and RNF168 in conjunction
with WRAP53β,3 has an important role in the downstream
recruitment of repair factors.3,21–25 Repair foci containing
WRAP53β were also enriched in conjugated ubiquitin
(detected using the FK2 (antibody clone recognizing K29-,
K48- and K63-linked polyubiquitylated and monoubiquitylated
protein) antibody) (Figure 2b), as well as in tumor protein p53
binding protein 1 (53BP1) (Figures 2b and c), a downstream
repair factor that requires ubiquitin signaling for its recruitment
to DNA breaks.3 Thus, we conclude that WRAP53β-mediated
targeting of repair factors to DNA double-strand breaks is not
disturbed in cells that overexpress WRAP53β.
Repair of double-strand breaks in DNA is enhanced in
cells that overexpress WRAP53β. Interestingly, in the cells
overexpressing WRAP53β clearance of γH2AX-containing
foci formed in response to irradiation was more rapid than in
control cells (Figure 3a), indicating faster DNA repair. More-
over, comet assays revealed that the cells overexpressing
WRAP53β contained fewer DNA breaks both 1 and 4 h after
irradiation (Figure 3b).
To examinewhether more efficient DNA repair could explain
these differences, we measured the efficiency of homologous
recombination (HR) and non-homologous end-joining (NHEJ),
repair pathways involved in the repair of double-strand breaks,
using green fluorescent protein (GFP)-reporter assays.26,27
In the case of HR, this assay involves U2OS cells carrying the
direct repeat–GFP recombination construct, in which expres-
sion of exogenous I-SceI introduces a single double-strand
break and repair of this break by HR produces a functional
GFP. The NHEJ assay works in a similar manner, except that
the GFP reporter (EJ5-GFP) contains two I-SceI sites, which
upon cleavage generate two incompatible DNA ends repaired
by NHEJ. Strikingly, transient overexpression of Flag-
WRAP53β enhanced the efficiency of HR and NHEJ by ~ 4-
fold (Figure 3c). Thus, we conclude that in cells overexpres-
sing WRAP53β, HR and NHEJ are more efficient and
consequently repair of DNA breaks more rapid.
Overexpression of WRAP53β enhances DNA repair by
promoting RNF8-mediated ubiquitylation of histones.
WRAP53β orchestrates repair of DNA double-strand breaks
by recruiting the critical ubiquitin ligase RNF8 to DNA
lesions.3 Ubiquitylation of histone H2AX, a known target of
RNF8 at sites of DNA damage, was clearly elevated in cells
overexpressing WRAP53β following irradiation (Figure 4a)
and knockdown of RNF8 attenuated this effect (Figure 4b),
suggesting that overexpression of WRAP53β stimulates
RNF8-regulated ubiquitylation of damaged chromatin. In
agreement with this idea, overexpression of RNF8 itself
enhanced the efficiency of both HR and NHEJ repair to an
extent similar to overexpression of WRAP53β (Figure 4c).
Altogether, these findings indicate that overexpression
of WRAP53β facilitates repair of DNA breaks by promoting
RNF8-mediated ubiquitylation of associated histones, a
process important for the assembly of downstream repair
factors.
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Overexpression of WRAP53β promotes cells' survival
following DNA damage. Tumors exhibiting altered
responses to DNA damage can be either hypersensitive or
resistant to genotoxic drugs. Interestingly, 70% of the control
cells, but only 23% of those overexpressing WRAP53β,
were apoptotic 5 days after irradiation (Figure 5a). The latter
were also less sensitive to other genotoxic agents, including
ultraviolet (UV) rays (42–47% reduction in the extent
of apoptosis), mitomycin C (MMC; 68–72% decrease),
hydroxyurea (HU; 59–68% decrease) and camptothecin
(CPT; 66–73% decrease) (Figure 5b).
Examination of the apoptotic response following DNA
damage in these cells revealed reduced proapoptotic signal-
ing (p53, PUMA, BAX) in cells overexpressing WRAP53β
compared with control cells and upregulation of the anti-
apoptotic protein Bcl-2 in the former (Figure 5c), indicating that
an altered apoptotic program may contribute to the resistance
of WRAP53β-overexpressing cells to genotoxic agents.
Figure 1 Overexpressed WRAP53β disrupts Cajal bodies and the overexpressed protein is mainly soluble. (a) Western blotting of the levels of WRAP53β in Mock
(endogenous WRAP53β) or 1xFlag-WRAP53β (overexpressing WRAP53β) U2OS cells with WRAP53-C2 or WRAP53-1F12 antibodies. β-Actin was used as a loading control.
Asterisk indicates unspecific bands. (b) Mock or Flag-WRAP53β U2OS cells were immunostained for WRAP53β (with WRAP53-C2 or WRAP53-1F12 antibodies) and coilin
(a marker for Cajal bodies). In all immunofluorescent stainings, nuclei were stained with DAPI. (c) The soluble proteins in Mock and Flag-WRAP53β U2OS cells were removed by
extraction before fixation with paraformaldehyde and immunostained for WRAP53β and coilin. (d) Western blotting of the soluble and chromatin proteins of Mock and Flag-
WRAP53β U2OS cells. Equal volumes from each fraction were loaded onto the gels. HSP90 and histone 4 were employed as markers for the soluble and chromatin fractions,
respectively. The slower migration of the chromatin proteins of WRAP53β on the SDS gel compared to its soluble counterpart may be due to additional modifications of this protein
when bound to chromatin. * indicates unspecific bands or bands of unknown origin
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Figure 2 WRAP53β accumulates at DNA double-strand breaks in cells overexpressing this protein. (a) Mock or Flag-WRAP53β cells were left untreated or irradiated (IR)
with 6 Gy, and 1 h later, their soluble proteins were removed by pre-extraction and the cells were then immunostained for WRAP53β (with WRAP53-1F12 antibody) and γH2AX.
The numbers represent the percentage of 100–200 cells counted whose nuclei contained 410 WRAP53β or γH2AX foci. Means± S.D. are shown, n= 3. (b and c) After
irradiation and pre-extraction as above, Flag-WRAP53β cells were immunostained for the proteins indicated. The FK2 antibody recognizes conjugated ubiquitin
Figure 3 Overexpression of WRAP53β enhances the repair of double-strand breaks. (a) The percentage of 200 Mock and Flag-WRAP53β cells counted, irradiated with 6 Gy
and then fixed at the time-points indicated, whose nuclei contained410 γH2AX foci. (b) Alkaline Comet assay of Mock and Flag-WRAP53β cells, either untreated (control) or
exposed to 20 Gy IR, and then allowed to recover for 0, 1 or 4 h. The tail moment of 200 comets were analyzed for each experiment, n⩾ 3. (c) FACS analysis of HR and NHEJ
efficiency following transient transfection of U2OS cells with the 3xFlag-Empty or 3xFlag-WRAP53β vectors for 48 h. In all cases, the values presented are means± S.D., n= 3.
*Po0.05, **Po0.01 and ***Po0.001, as determined by Student’s t-test
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Furthermore, we examined the growth rate of these cells,
as DNA-damaging drugs most effectively eliminate rapidly
dividing cells, while quiescent or slow-cycling cells are less
susceptible.28 Interestingly, cells overexpressing WRAP53β
grow slower than control cells (Figure 5d). The lower amount
of cells overexpressing WRAP53β at 48 or 96 h after seeding
compared with control cells was not because of apoptosis
(Figure 5b – NT fraction) or cell cycle arrest (Figure 5e).
However, the cell cycle distribution was slightly different
between cells overexpressing WRAP53β and control cells,
with more cells in the G1 phase and less in the S phase for the
former, whereas the amount of cells in the G2 phase was the
same for both cell lines. Taken together, our results demon-
strate that overexpression of WRAP53β results in faster DNA
repair, an altered apoptotic response and slower proliferation/
cycling, thereby promoting cell survival following DNA
damage.
Discussion
Although high levels of WRAP53β, a scaffold protein involved
in the intracellular trafficking of factors to Cajal bodies and
DNA breaks,3,5,29 are present in various cancers,16–20 it
remains unclear how such overexpression may alter its
functions. Here we report that overexpression of WRAP53β
disturbs its recruitment and maintenance of factors to Cajal
bodies, while at the same time enhancing the repair of DNA
double-strand breaks. In cancer cells stably overexpressing
this protein, WRAP53β was mislocalized in the nucleoplasm,
in agreement with previous findings.5 Coilin, a marker protein
Figure 4 Overexpression of WRAP53β enhances histone ubiquitylation by RNF8. (a) Mock and Flag-WRAP53β cells were irradiated with 6 Gy and then allowed to recover
for 1 h, after which western blotting for WRAP53β, H2AX and β-actin was performed. (b) Mock or Flag-WRAP53β cells were treated with the siRNAs indicated for 48 h, then
irradiated with 6 Gy and allowed to recover for 1 h, after which western blotting for WRAP53β, RNF8, H2AX and β-actin was performed. (c) FACS analysis of HR and NHEJ
efficiency following transient transfection of U2OS cells with the 1xFlag-Empty, 1xFlag-WRAP53β or 1xFlag-RNF8 vectors for 48 h. The values presented are means± S.D.,
n= 3. **Po0.01 and ***Po0.001, as determined by Student’s t-test
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Figure 5 Cells that overexpress WRAP53β are less sensitive to apoptosis induced by DNA damage. (a) Mock and Flag-WRAP53β cells were irradiated (10 Gy), harvested
96 or 120 h later and analyzed by FACS for positive staining with Annexin V-PI, an indicator of apoptosis. (b) Mock and Flag-WRAP53β cells were treated with UV (30 J/m2), MMC
(1 μg/ml), HU (500 μM), CPT (50 nM) or nothing (NT control) for 96 or 120 h, harvested and analyzed for Annexin V-PI positivity by FACS. (c) Mock and Flag-WRAP53β cells
were left untreated (NT), irradiated (10 Gy) or treated with CPT (50 nM), harvested 72 h later and analyzed by western blotting for indicated proteins. (d) A total of 10 000 cells per
ml of Mock and Flag-WRAP53β cells were seeded in 6-well plates, grown for 48 or 96 h, harvested and counted. The values presented are cells per ml. (e) Mock and Flag-
WRAP53β cells were seeded, grown for 48 or 96 h, harvested, stained with PI and subjected to flow cytometry. The numbers indicate the % of cells in each cell cycle phase.
Asterisk indicates the significance between the values in Flag-WRAP53β cells compared to the corresponding value in control cells. Percentages of sub-G1 and super-G2 are not
shown. In all cases, the values presented are means± S.D., n= 3. *Po0.05, **Po0.01 and ***Po0.001, as determined by Student’s t-test
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for the Cajal body, demonstrated similar mislocalization, and
thus no Cajal bodies appeared to have been formed. It is
important to note that the overexpression in our cells was
relatively high and that cells overexpressing WRAP53β at
lower levels are still capable of forming Cajal bodies.5
Moreover, these cells only overexpress the open-reading
frame of the protein and not the sequence of the WRAP53α
transcript involved in regulating p53.
Intriguingly, in contrast to its absence from Cajal bodies,
WRAP53β still localized to sites of DNA damage sites in
overexpressing cells. Most of the overexpressed WRAP53β
was soluble and may have competed with endogenous
soluble WRAP53β for factors important for localization of this
protein and associated factors. If soluble WRAP53β controls
targeting of factors to Cajal bodies and the chromatin-bound
fraction participates in DNA repair, this could explain why
only its function related to the Cajal body are disrupted by
overexpression.
Indeed, WRAP53β translocates certain components,
including the SMN complex, from the cytoplasm to Cajal
bodies,5 suggesting the involvement of a more mobile form of
WRAP53β. Moreover, Cajal bodies alternate between passive
diffusion within the nucleoplasm and transient immobilization
through association with chromatin. In contrast, WRAP53β is
recruited to sites of DNA damage from the nuclear pool alone,
that is, no cytoplasmic shuttling is involved.4 In addition, many
repair factors are bound to chromatin even before damage,
allowing rapid redistribution to damaged sites when needed.
Our present observations also show that overexpression of
WRAP53β enables more rapid repair of DNA double-strand
breaks by HR and NHEJ. An open chromatin configuration
allows more efficient repair of DNA double-strand breaks,
providing greater resistance to such damage.30 Ubiquitylation
of damaged chromatin is rate limiting for the accumulation of
downstream repair factors,3,21–24 and, indeed, we found that
overexpression of WRAP53β elevated ubiquitylation of H2AX.
Knockdown of the ubiquitin ligase involved, RNF8, abrogated
this effect in agreement with our previous report that
WRAP53β targets RNF8 to DNA breaks.3
Rapid exchange of RNF8 at sites of DNA damage and the
small number of copies of this protein in repair foci have been
proposed to reflect its rate-limiting role in repair.31 Over-
expression of WRAP53β may increase the level of RNF8 in
repair foci by tethering it to damaged chromatin, thus slowing
down its otherwise rapid turnover and promoting ubiquityla-
tion. Our finding that overexpression of RNF8 itself enhanced
HR and NHEJ repair supports the suggestion that elevating
its local concentration may boost its action at DNA breaks.
Moreover, RNF8 promotes decondensation of damaged
chromatin by recruiting the chromatin-remodeling factor
CHD4 (chromodomain helicase DNA-binding 4)32 and it is
possible that WRAP53β aids in this decondensation, thereby
enhancing chromatin accessibility to DNA repair. However,
further investigation of the potential role of WRAP53β in the
organization of chromatin is required.
Overexpression of WRAP53β also enhances cells survival
following exposure to radiation and other DNA-damaging
agents. We showed earlier that knockdown of WRAP53β in
cancer cell lines, including the U2OS cells examined
here, triggers mitochondria-dependent apoptosis and that
overexpression of Bcl-2 protects against this apoptosis.16
Thus, Bcl-2 and/or other antiapoptotic proteins may be
upregulated in cells that overexpress WRAP53β, protecting
them from apoptosis. Indeed, we observed higher expression
of Bcl-2 in these cells as well as diminished proapoptotic
signaling. Moreover, we reveal that cells overexpressing
WRAP53β proliferate significantly slower than cells with
endogenous expression of this protein. Thus, it appears like
cells overexpressing WRAP53β have acquired multiple
resistance mechanisms, including increased DNA repair,
overexpression of the antiapoptotic protein Bcl-2 and slow
cycling, rendering them less sensitive to initiation of apoptosis
by DNA damage.
The contradictory findings concerning the contribution of
WRAP53β to cancer may involve timing. Inactivation could
help initiate tumor development by impairing DNA repair
and telomere maintenance and causing genomic instability.
Indeed, inactivation of WRAP53β as a result of inherited
mutations leads to the cancer susceptibility-disorder dysker-
atosis congenita.7 In contrast, overexpression could be a
late event in tumor progression, enhancing DNA repair in
transformed cells suffering from replication stress and thereby
promoting their maintenance and survival. Alternatively, high
expression of WRAP53β observed in primary tumors could
reflect accumulation of misfolded inactive WRAP53β, as
mutations in this protein disrupt its folding by the chaperonin
TRiC, which results in cytoplasmic accumulation and lost
nuclear activity of mutated WRAP53β.9,33 Similarly, p53 was
initially believed to be an oncogene because of its over-
expression in cancer, but later on found to be a tumor
suppressor frequently inactivated in cancer, where the
mutations cause overexpression of inactive p53 owing to
reduced degradation of the protein.34 In any case, under-
standing the function of WRAP53β in health and diseases,
such as cancer, may open novel therapeutic strategies.
Materials and Methods
Cells and culture conditions. Mock and Flag-WRAP53β U2OS cells were
maintained in McCoy’s 5A medium (HyClone, Thermo Scientific, Stockholm,
Sweden), selected with 10 μg/ml blasticidine S (InvivoGen), and DR-GFP and EJ5-
GFP U2OS cells were maintained in high glucose DMEM (HyClone), supplemented
with 10% fetal bovine serum (Hyclone) and 2.5 μg/ml plasmocin (InvivoGen) at 37 °
C in 5% CO2 humidified chamber. Flag-WRAP53β cells overexpress the open-
reading frame of the protein tagged with 1xFlag.
Antibodies
Primary: Rabbit α-WRAP53-C2 (cat. no. PA-2020-100; Innovagen AB, Lund,
Sweden), mouse monoclonal α-WDR79 (clone 1F12, cat. no. H00055135-M04;
Abnova, Stockholm, Sweden), mouse α-coilin (cat. no. sc-56298; Santa Cruz
Biotechnology, Heidelberg, Germany), rabbit α-coilin (cat. no. sc-32860; Santa Cruz
Biotechnology), mouse α-γH2AX (cat. no. 05-636; Millipore, Solna, Sweden), rabbit
α-γH2AX (cat. no. 2577; Cell Signaling, Danvers, MA, USA), mouse
α-conjugated ubiquitin (FK2) (cat. no. ST1200; Calbiochem, Millipore), rabbit α-
53BP1 (cat. no. NB100-904; Novus Biologicals), rabbit α-H2AX (cat. no. ab11175;
Abcam), mouse α-RNF8 (cat. no. sc-271462; Santa Cruz Biotechnology), rabbit
α-H4 (cat. no. ab10158; Abcam), mouse α-p53 (cat. no. sc-126; Santa Cruz), rabbit
α-PUMA (cat. no. ab9643; Abcam), rabbit α-BAX (cat. no. ab32503; Abcam),
mouse α-Bcl-2 (cat. no. M0887; Dako), rabbit α-p21 (cat. no. ab109199; Abcam)
and mouse heat-shock protein 90 (HSP90) α/β (cat. no. sc-13119; Santa Cruz
Biotechnology).
Secondary: Goat α-rabbit HRP (cat. no. 7074; Cell Signaling), horse α-mouse
HRP (cat. no. 7076; Cell Signaling), goat α-rabbit Alexa Fluor 488 (cat. no. A11008;
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Invitrogen, Thermo Scientific), goat α-mouse Alexa Fluor 488 (cat. no. A11029,
Invitrogen, Thermo Scientific), donkey α-rabbit Alexa Flour 594 (cat. no. A21207;
Invitrogen) and donkey α-mouse Alexa Fluor 594 (cat. no. A21203; Invitrogen).
Immunofluorescence microscopy. Cells grown on sterilized coverslips
were fixed with 4% paraformaldehyde for 15 min at room temperature. They were
then permeabilized with 0.1% Triton X-100 for 5 min at room temperature, followed
by 30 min of blocking in blocking buffer (2% bovine serum albumin (BSA), 5%
glycerol, 0.2% Tween-20, 0.1% NaN3). The coverslips were subsequently incubated
for 1 h in primary antibody, followed by 40 min in secondary antibody, both diluted in
blocking buffer, and finally mounted with Vectashield mounting medium containing
DAPI (4′,6-diamidino-2-phenylindole; Vector Laboratories, Burlingame, CA, USA).
Images were acquired with an LSM700 confocal microscope (Zeiss, Stockholm,
Sweden), mounted on Axio observer.Z1 (Zeiss) equipped with Plan-Apochromat
x63/1.4 oil immersion lens and processed with using Zen 2012 Black (Zeiss).
Pre-extraction: The cells were first washed with PBS and then incubated for
3 min at room temperature with cytoskeleton buffer (CSK) (10 mM Pipes, pH 7.0,
100 mM NaCl, 300 mM sucrose, 3 mM MgCl2 and 0.7% Triton X-100) and
thereafter for another 3 min with the same CSK buffer supplemented with 0.3 mg/ml
RNase A (CSK+R). Following these treatments, the cells were washed once again
with PBS and then fixed in 4% paraformaldehyde.
Western blotting. Cells were harvested, washed and lysed in ice-cold lysis
buffer (100 mM Tris-HCl, pH 8, 150 mM NaCl, 1% NP-40, 1% PMSF, 1% protease
inhibitor cocktail) for 30 min on ice followed by sonication. The lysates obtained
were centrifuged at 14 000 r.p.m. for 15 min at 4 °C and their protein concentrations
determined with the Bradford assay (Bio-Rad). Thereafter, western blotting was
performed by standard procedures.
Cell fractionation. Cells were harvested, washed in PBS and lysed in low salt
buffer (10 mM HEPES, pH 7.4, 10 mM KCl, 0.05% Nonidet P-40, 1 mM DTT, 1%
protease inhibitor cocktail) for 5 min on ice, followed by centrifugation at 3600 × g for
5 min at 4 °C. The supernatants were centrifuged again at 13 000 × g for 10 min at
4 °C. The supernatant (soluble proteins) was transferred to a new Eppendorf tube.
The pellet from the first centrifugation were washed two times in low salt buffer with
centrifugation at 3000 × g for 5 min at 4 °C between each wash. The remaining
pellet were lysed in nuclease buffer supplemented with micrococcal nuclease
(150 nM NaCl, 5 mM MgCl2, 1x micrococcal nuclease buffer, BSA, 2000 gel units
micrococcal nuclease (cat. no. M0247S; New England Biolabs, Ipswich, MA, USA)
for 10 min at 37 °C, followed by centrifugation at 13 000 × g for 10 min at 4 °C and
transferred to a new Eppendorf tube (chromatin proteins). The soluble and
chromatin fractions were adjusted to equal volumes. In Figure 1d, equal volumes of
each fraction were loaded on an SDS-PAGE gel, corresponding to ~ 50 μg of
soluble proteins and 3 μg of chromatin proteins.
Ionizing radiation. γ-Irradiation was performed with a 137Cs source
(Scanditronix, Uppsala, Sweden) at the Karolinska Institutet (Stockholm, Sweden),
at a photon dose rate of 0.5 Gy/min. Dosimetry was carried out with an ionization
chamber as well as with ferro sulfate.
Comet assay. The alkaline Comet assay was performed using the method
described earlier with some modifications.35 Briefly, cells were irradiated with 20 Gy.
After 0, 1 or 4 h, cells were harvested with trypsin and washed. A total of 150 000
cells were diluted in 300 μl PBS, of which 100 μl were mixed with 500 μl low-
melting-point agarose (1.2% (w/v) in PBS) to a final concentration of 1%. Of the
resulting suspension, 100 μl was layed on the top of a previously prepared normal-
melting-point agarose (1% (w/v) in PBS) on fully-frosted slides and the suspension
was covered with a 22x22 mm2 coverslip. The slides were put on ice for 10 min and
then immersed in lysis buffer (2.5 M NaCl, 100 mM sodium-EDTA, 10 mM Tri-HCl,
pH 10, 10% DMSO, 1% Triton X-100) for overnight at 4 °C in the dark. After lysis,
slides were placed in alkaline electrophoresis buffer (0.3 M NaOH, 1 mM sodium-
EDTA) for 30 min at room temperature to denature DNA and express alkali-labile
sites. Electrophoresis was carried out at room temperature for 30 min at 25 V,
300 mA in a Comet Assay Tank (Thistle Scientific, Glasgow, UK). The slides were
then washed two times in neutralizing buffer (0.4 M Tris-HCl, pH 7.4) for 30 min.
DNA was stained with 40 μl CybrGOLD diluted 1 : 1000 (Thermo Scientific). Two
slides were run and analyzed for each experiment. On each slide, 100 comets were
quantified at × 10 magnification using the Comet Assay IV Image analysis system
(Perceptive Instruments, Bury Saint Edmunds, UK) in live-video mode on a Zeiss
Axiovert 35 fluorescent microscope (Zeiss). Tail moment (arbitrary unit) is defined
as the product of the tail length and the fraction of total DNA in the tail. Images were
acquired using the same software. For the statistical analysis, a two-way ANOVA
analysis was performed in GraphPad Prism software (GraphPad Software, La Jolla,
CA, USA).
Drug treatment. In all, 1 μg/ml MMC (cat. no. 10107409001; Roche,
Stockholm, Sweden), 500 μM HU (cat. no. H8627; Sigma-Aldrich), 50 nM CPT
(cat. no. C9911; Sigma-Aldrich, Stockholm, Sweden) were added to cells for 96 or
120 h.
FACS analysis. For the analysis of apoptosis, cells were exposed to genotoxic
agents and harvested at the indicated time-points with trypsin. Next, the samples
were incubated with incubation buffer (10 mM HEPES (pH 7.4), 140 mM NaCl,
2.5 mM CaCl2) supplemented with Annexin-V-FLUOS (cat. no. 11828681001;
Roche) and 0.1% propidium Iodide (PI) solution (cat. no. P4864; Sigma-Aldrich) for
15 min at room temperature. The cells were then dissolved in incubation buffer and
analyzed for active Annexin V-PI staining by flow cytometry on a FACS Calibur
(Becton Dickinson, Erembodegem, Belgium) using the Cell Quest software (Becton
Dickinson). The sum of the Annexin V+-P− (early apoptosis) and Annexin V+-PI+
(late apoptosis) population of cells were accounted as apoptotic cells.
For the analysis of the cell cycle, cells were seeded and 48 or 96 h later harvested
with trypsin, washed in PBS and fixed in 60% ethanol overnight at 4 °C. After removal
of the ethanol, the samples were incubated with a solution of RNase A/PI for 30 min
at 37 °C and subsequently analyzed with a NovoCyte apparatus (ACEA
Biosciences Inc., San Diego, CA, USA).
HR and NHEJ assays. A total of 300 000 cells were seeded into 6-well
plates. After 24 h, cells were transfected with an I-SceI vector together with a vector
expressing Flag-Empty, Flag-WRAP53β or Flag-RNF8 using Lipofectamine 2000
(Invitrogen). 1xFlag vector corresponds to pCMV-Tag2 vector (Invitrogen) and
3xFlag vector to p3xFlag-CMV-9 (Sigma-Aldrich). The next day, media were
changed, and 24 h after this, cells were harvested by trypsination, washed with PBS
and the GFP signal arising from the recombination event was measured by flow
cytometry on a FACS Calibur (as described above), with fluorescence detected in
the FL1-H channel (logarithmic scale). The frequency of repair in cells transfected
with the various plasmids was calculated relative to cells transfected with the empty
plasmid. Each data point represents the mean± S.D. from three independent
experiments.
Cell count analysis. Cells were seeded and 48 or 96 h later harvested and
counted using a Bürker chamber Brand (Sigma-Aldrich).
siRNA transfections. Ten nanomoles of small interference RNA (siRNA),
siRNF8 (cat. no. L-006900-00-0005; Dharmacon, Karlskoga, Sweden) or siControl
(cat. no. 1027280, Qiagen), was transfected into cells using HiPerfect (Qiagen,
Sollentuna, Sweden) transfection reagent in accordance with the supplier’s
recommendations.
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